The estimated Net Worth of Antoinette Paone is at least $166 Tisíc dollars as of 15 July 2024. Ms Paone owns over 1,592 units of Generation Bio Co stock worth over $37,574 and over the last 3 years she sold GBIO stock worth over $128,675.
Ms has made over 18 trades of the Generation Bio Co stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 1,592 units of GBIO stock worth $3,884 on 15 July 2024.
The largest trade she's ever made was exercising 10,492 units of Generation Bio Co stock on 15 January 2024 worth over $25,600. On average, Ms trades about 3,460 units every 35 days since 2022. As of 15 July 2024 she still owns at least 15,399 units of Generation Bio Co stock.
You can see the complete history of Ms Paone stock trades at the bottom of the page.
Antoinette Paone M.B.A., M.S. is the Sr. VP & Head of Regulatory Affairs and Quality at Generation Bio Co.
Antoinette's mailing address filed with the SEC is C/O GENERATION BIO CO., 301 BINNEY ST, , CAMBRIDGE, MA, 02142.
Over the last 4 years, insiders at Generation Bio Co have traded over $37,722,950 worth of Generation Bio Co stock and bought 4,282,125 units worth $70,408,633 . The most active insiders traders include Jason P Rhodes, Biomedical Innovation Maste... a Public Equities, L.P.Minne .... On average, Generation Bio Co executives and independent directors trade stock every 11 days with the average trade being worth of $116,471. The most recent stock trade was executed by Yalonda Howze on 15 July 2024, trading 3,347 units of GBIO stock currently worth $8,167.
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co executives and other stock owners filed with the SEC include: